Business Express is an online portal that covers the latest developments in the world of business and finance. From startups and entrepreneurship to mergers and acquisitions, Business Express provides reporting on the stories that matter most to business leaders and decision-makers.The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
2023 03 30T060618Z 1 LYNXMPEJ2T06A RTROPTP 4 PHILIPS RESULTS
2023 03 30T060618Z 1 LYNXMPEJ2T06A RTROPTP 4 PHILIPS RESULTS

Philips expects to reach recall settlements this year


AMSTERDAM (Reuters) – Dutch health technology company Philips expects to reach settlements this year relating to its global recall of respiratory devices, CEO Roy Jakobs said in an interview with Dutch financial daily FD published on Thursday.

“I think we can at least reach a settlement on economic damages this year,” Jakobs said without giving details on the expected costs.

Jakobs added he “hopes and expects” to also reach a settlement with the U.S. Food and Drug Administration this year.

A settlement with patients who claim the use of the recalled machines made them sick probably will take longer, he said.

A spokesperson for Philips confirmed the quotations in the newspaper were accurate.

Shares in the Amsterdam-listed company were up 3.9% to 16.14 euros at 0729 GMT.

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

The company recalled millions of breathing devices and ventilators used to treat sleep apnea in 2021 because foam used to dampen noise from the devices might degrade and become toxic, carrying potential cancer risks.

Fears of large litigation bills have since wiped 70% off Philips’ market value.

The economic damages claim was made by people, hospitals and health plans who say they suffered economic losses when the millions of machines were recalled.

 

(Reporting by Bart Meijer; Editing by Muralikumar Anantharaman and Mark Potter)

 

Recent Post: